Regorafenib is a synthetic compound studied as an active pharmaceutical ingredient, characterized by an aromatic, halogen-containing structure. Its crystalline forms and monohydrate have been investigated for structural properties relevant to pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 755037-03-7
Regorafenib monohydrate
pharmaceutical raw material
Sorafenib
Multikinase inhibitor for cancer research
Sorafenib tosylate
pharmaceutical raw material
Flupirtine maleate
pharmaceutical raw material
(R)-colchicine
pharmaceutical raw material
Ingenol mebutate
pharmaceutical raw material
Fludarabine phosphate
pharmaceutical raw material
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
pharmaceutical intermediate
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
FNHKPVJBJVTLMP-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F